Intervention Review

You have free access to this content

Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children

  1. Diane M Gray1,*,
  2. Taryn Young2,
  3. Mark Cotton3,
  4. Heather Zar4

Editorial Group: Cochrane HIV/AIDS Group

Published Online: 7 OCT 2009

Assessed as up-to-date: 20 MAR 2006

DOI: 10.1002/14651858.CD006418.pub2

Database Title

Additional Information

How to Cite

Gray DM, Young T, Cotton M, Zar H. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD006418. DOI: 10.1002/14651858.CD006418.pub2.

Author Information

  1. 1

    Groote Schuur Hospital, G25 HIV/AIDS Paediatric Service, Cape Town, Western Cape, South Africa

  2. 2

    Medical Research Council, South African Cochrane Centre, Tygerberg, South Africa

  3. 3

    Tygerberg Children's Hospital, Children's Infectious Diseases Clinical Research, Tygerberg, Cape Provice, South Africa

  4. 4

    University of Cape Town, 5th floor ICH Building, Department of Paediatric Pulmonology, School of Child and Adolescent Health, Red Cross Childrens Hospital, Capre Town, South Africa

*Diane M Gray, G25 HIV/AIDS Paediatric Service, Groote Schuur Hospital, Cape Town, Western Cape, 7700, South Africa. diane@kidzpositive.org. graysteven@mweb.co.za.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 7 OCT 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (61K)Standard (201K)Full (211K)

References

References to studies included in this review

  1. References to studies included in this review
  2. References to ongoing studies
  3. Additional references
Zar 2007 {published data only}
  • Zar HJ, Cotton MF, Strauss S, Karpakis J, Hussey G, Schaaf HS, et al. Effect of isoniazid prophylaxis on mortality and incidence of tuberculosis in children with HIV: randomised controlled trial. Lancet 2007;334:136-42.

References to ongoing studies

  1. References to studies included in this review
  2. References to ongoing studies
  3. Additional references
Madhi {published data only (unpublished sought but not used)}
  • Madhi S, McSherry G, Mitchell CD. Tuberculosis in infants born to mothers with HIV. www.http://clinicaltrials.gov/show/NCT00080119 (accessed 11 June 2008).
Zar {published data only (unpublished sought but not used)}
  • Zar HJ, Cotton M. Isoniazid prophylaxis with concomitant cotrimoxazole in HIV-infected children. www.http://clinicaltrials.gov/show/NCT00330304 (accessed 11 June 2008).

Additional references

  1. References to studies included in this review
  2. References to ongoing studies
  3. Additional references
Barnes 1991
Berggren Palme 2002
  • Berggren Palme I, Gudetta B, Bruchfield J, Muhe L, Giesecke J. Impact of human immunodeficeincy virus 1 infection on clinical presentation, treatment outcome and survival in a cohort of Ethiopian children with tuberculosis. Pediatric Infectious Disease Journal 2002;21:1053-61.
Burman 2005
Chintu 2005
  • Chintu C, Mwaba P. Tuberculosis in children with human immunodeficiency virus infection. The International Journal of Tuberculosis Lung Disease 2005;9(5):477-84.
Corbett 2003
  • Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, et al. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Archives of Internal Med 2003;163:1009-21.
Curtis 1999
Donald 2000
  • Donald PR. Childhood tuberculosis. Current Opinion in Pulmonary Medicine 2000;6:187-92.
Donald 2002
Foster 2003
  • Foster K, Alton H. Chronic lung infection in children. Paediatric Respiratory reviews 2003;4:225-9.
Goletti 1996
  • Goletti D, Weisman D, Jackson RW, Graham NM, Vlahov D, Klein RS, et al. Effect of mycobacterium tuberculosis on HIV replication: role of immune activation. Journal of Immunology 1996;157:1271-8.
Hesseling 2005
  • Hesseling AC, Westra AE, Werschkull H, Donald PR, Beyers N, Hussey GD, et al. Outcome of HIV infected children with culture confirmed tuberculosis. Archives of Disease in Childhood 2005;90:1171-4.
Higgins 2002
  • Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21:1539-58.
    Direct Link:
Higgins 2006
  • Higgins JPT, Green S, editors. Cochrane handbook for Systemic Reviews of Interventions 4.2.6 [updated September 2006]. www.cochrane.org/resources/handbook/hbook.htm (accessed Feb 2006).
Jeena 1998
Jeena 2002
  • Jeena PM, Pillay P, Pillay T, Coovadia HM. Impact of HIV-1 co-infection on presentation and hospital-related mortality in children with culture proven pulmonary tuberculosis in Durban, South Africa. The International Journal of Tuberculosis and Lung Disease 2002;6:672-8.
Kochi 1991
Marais 2005
  • Marais BJ, Obihara CC, Warren RM, Schaaf HS, Gie RP, Donald PR. The burden of childhood tuberculosis: a public health perspective. The International Journal of Tuberculosis and Lung Disease 2005;9(12):1305-13.
Mukadi 1997
  • Mukadi YD, Wiktor Z, Coulibaly IM, Coulibaly D, Mbengue A, Folquet AM, et al. Impact of HIV infection on the development, clinical presentation and outcome of tuberculosis among children in Abidjan, Cote d'Ivoire. AIDS 1997;11(9):1151-8.
Narita 1998
  • Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. American Journal of Respiratory and Critical Care Medicine 1998;158(1):157-61.
Nelson 2004
Perriens 1995
  • Perriens JH, St Louis ME, Mukadi YB, Brown C, Prignot J, Pouthier F, et al. Pulmonary tuberculosis in HIV-infected patients in Zaire. A controlled trial of treatment for either 6 or 12 months. New England Journal of Medicine 1995;332(12):779-84.
Puthanakit 2006
  • Puthanakit T, Oberdorfer P, Akarathum N, Wannarit P, Sirisanthana T, Sirianthana V. Immune Reconstitution Syndrome After Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus-Infected Thai Children. Pediatric Infectious Disease Journal 2006;25(1):53-8.
RevMan Analyses 2004
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan) [computer program]. 4.2 for Windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2004.
Schaaf 1998
  • Schaaf HS, Geidenduys A, Gie RP, Cotton MF. Culture-positive tuberculosis in human immunodeficiency virus type-1-infected children. Pediatric Infectious Disease Journal 1998;7:599-604.
Schaaf 2005
  • Schaaf HS, Krook S, Hollemans DW, Warren RM, Donald PR, Hesseling AC. Recurrent Culture-Confirmed Tuberculosis in Human Immunodeficiency Virus-Infected Children. Pediatric Infect Disease Journal 2005;24(8):685-91.
Smieja 1999
  • Smieja MJ, Marchettu CA, Cook DJ, Smaill FM. Isoniazid for preventing tuberculosis in non-HIV infected persons. Cochrane Database of Systematic Reviews 1999, Issue 1. [Art. No.: CD001363. DOI: ]
Thompson 1982
  • Thompson NJ. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bulletin of the World Health Organisation 1982;60:555-64.
UNAIDS/WHO 2005
  • UNAIDS/WHO. AIDS epidemic update: December 2005. www.unaids.org (accessed 23 February 2006).
van Rie 1999
  • van Rie A, Beyers N, Gie RP, Kunneke M, Zietsman L, Donald PR. Childhood tuberculosis in an urban population in South Africa: burden and risk factors. Archives of Disease in Childhood 1999;80:433-7.
Woldehanna 2004
  • Woldehanna S, Volmink J. Treatment of latent infection in HIV infected persons. Cochrane Database of Systematic Reviews 2004, Issue 1.
Zar 2001
  • Zar HJ, Manslo D, Tannebaum E, Klein M, Argent A, Eley B, et al. Aetiology and outcome of pneumonia in humman immunodeficiency virus-infected children hospitalized in South Africa. Acta Paediatrica 2001;90(2):119-25.
View Full Article (HTML) Summary (61K)Standard (201K)Full (211K)